Opioid Use Disorder at AAAP 37th Annual Meeting and Scientific Symposium
48 sessions on opioid use disorder · November 12–15, 2026, Memphis, TN. Compare opioid use disorder at other meetings →
Friday, November 13
10:40–12:10 · Session · Case Conference
An ICD for Harm Reduction: Methadone-Associated Torsades de Pointes in a Patient With Opioid Use Disorder
Case of a man with opioid use disorder who developed torsades de pointes on methadone and other QT-prolonging exposures. Discusses withdrawal management, methadone retitration, and the decision to place a subcutaneous ICD as a harm reduction measure.
Drug Interactions & Safety · Medical Comorbidity & C-L Psychiatry
15:30–17:00 · Oral abstract
Medications for Opioid Use Disorder in VHA Acute Care Settings: A Quality Improvement Study
Quality improvement study of MOUD delivery in VHA acute care settings.
15:30–17:00 · Oral abstract
Nearcasting the Overdose Crisis: Key Insights from US Drug Dynamics
Presents near-real-time modeling of US overdose and drug supply trends.
15:30–17:00 · Oral abstract
The Overdose Crisis is Not Over: Race, Age, and Sex Disparities in Opioid-Related Acute Care, 2016–2023
Analyzes racial, age and sex disparities in opioid-related acute care use.
15:30–17:00 · Oral abstract
Prize-based versus Voucher-based Contingency Management protocols for Stimulant-Opioid Co-Use: A Network Meta-Analysis
Network meta-analysis comparing prize- and voucher-based contingency management for stimulant-opioid co-use.
15:30–17:00 · Oral abstract
When Prescribed Opioids Fail: Comparing Recall Patterns between Medications for Opioid Use Disorder versus Other Opioids Used for Pain
Compares product recall patterns for medications for opioid use disorder and opioids prescribed for pain.
15:30–17:00 · Oral abstract
Housing Status Reporting and Pooled Prevalence of People Experiencing Housing Instability in Opioid Use Disorder Pharmacotherapy Trials: A Systematic Review and Meta-analysis
Systematic review of how OUD medication trials report and include people with housing instability.
Sunday, November 15
Posters (39)
- Bone Health Outcomes Among Patients with Opioid Use Disorder: Buprenorphine vs. Methadone Across Two Complementary Analyses — Claire Drotman
- Bridging the Gap: Embedding Addiction Counselors in Inpatient Care to Improve Transitions of Care for Patients with Opioid Use Disorder (OUD) — Ann Brandt
- Case Report: Transition from High-Dose Methadone to Buprenorphine over 14 Days on a Standard Medical Inpatient Unit — Gloria Pereira
- Association between Methadone Dose and Long-Term Retention in Patients Using Fentanyl — Zachary Bosshardt
- Beyond Naloxone: A Hospital-Wide Harm Reduction Training Improves Resident Physician Knowledge, Confidence, and Attitudes Across Specialties — Samantha Getsin
- Feasibility of Multimodal In Vivo Assessment of Psilocybin in Opioid Use Disorder: A Case Series — Julia Shatalov
- Designing a Contingency Management App to Support Opioid Agonist Therapy — Jade Wong
- From Methadone 200 mg/day to Brixadi: Successful Inpatient Transition Using Low-Dose Buprenorphine Induction for Persistent QTc Prolongation — Michelle Williamson
- Immuno-Endocrine Dynamics of Opioid Withdrawal Syndrome: A Narrative Review" to "Stress Hormone Dynamics of Opioid Withdrawal Syndrome: A Narrative Review — Nazli Tunali
- Detangling a Complex Network: A Framework and Components for Comprehensive Naloxone Community Distribution — Carrie Mills
- From Opioid Avoidance to Kratom Dependence: Treatment of Kratom Use Disorder with Long-Acting Injectable Buprenorphine — Alejandro Lopez
- Incidence of Precipitated Withdrawal Following Rapid Initiation of Weekly and Monthly Extended-Release Injectable Buprenorphine in Adults With Moderate-to-Severe Opioid Use Disorder Not Currently Receiving Buprenorphine: A Study Protocol — Natalie Budilovsky-Kelley
- Increasing Narcan Prescriptions at Discharge from Inpatient Psychiatry Admission at UConn Health through Implementation of an EMR Clinical Decision Support Alert — Cristina Perez Caro
- Optimizing Outreach and Engagement for Substance Use Disorder Training: An Analysis of Opioid Response Network (ORN) Strategies to Enhance Public Health Priorities — Nic Canning
- Medetomidine? What Happened to Xylazine?!?! A Case Example from Philadelphia and Literature Review — Paul Grey
- Kratom and 7OH: The 5th Wave of the Opioid Crisis — Arthur Robin Williams
- Predictors of Buprenorphine Retention following Emergency Department-Initiated Opioid Use Disorder Program — Haley Kvarnberg
- Methadone Effect on Mood Compared to Other Opioid Agonist Therapies in Patients with Opioid Prescriptions: A Systematic Literature Review and Meta-Analysis — Alyssa Xiong
- Laissez Les MOUD Rouler: Laying the Foundation for Emergency Department Buprenorphine Expansion in Louisiana Using the Bridge Starts Curriculum — Jordan Brandt
- Latent Psychiatric Subtypes and Treatment Outcomes in Opioid Use Disorder: A Secondary Analysis of CTN-0094 — Tobias Atkin
- Multivariable Prediction of Domain-Specific Reward Availability in Opioid Use Disorder: Mindfulness, Loneliness, and Sleep Quality as Independent Psychological Correlates — Arnav Garyali
- Recent Cocaine Use as a Predictor of 12-Month Treatment Engagement among Women Receiving Methadone Maintenance Treatment — Shai Smith
- The Opioid Response Networks Naloxone and Saturation Mapping Training for Tribes — Johnna James
- Recent Rapid Induction Techniques in Patients Transitioning from Methadone to Buprenorphine — Peter Wilson-Braun
- Trends in Buprenorphine Prescribing by Provider Type and Patient Race in a Large Academic Health System, 2020-2025 — Chaden Noureddine
- Unsupervised Anabolic Steroid Use in a Patient on Methadone Maintenance Therapy: A Case Report Highlighting Gaps in Care Coordination and the Role of Addiction Psychiatry — William Jangro
- Use of Diazoxide in Management of Methadone-Induced Hypoglycemia — Morgan Barnett
- Supplementary Pathway for Medically Monitored Ibogaine for Opioid Use Disorder: A National Semi-Markov Cost-Effectiveness Analysis — T Wagner
- What is SR-17018? A Literature Review and Social Media Analysis of Real-World Use — Sarah Cheema
- Sex Differences in Pain Relief as the Primary Motivation for Prescription Pain Reliever Misuse among U.S. Adults, 2015-2024 — Soohyun Joe
- Short- And Long-Term Methadone Dose Trajectories in Patients Testing Positive versus Negative for Fentanyl at Treatment Initiation — Yilang Tang
- Ocular Complications, Withdrawal, and Successful Naltrexone Treatment in Kratom Use Disorder: A Case Report — Yazmine Krentsa
- 48-Hour Transdermal Buprenorphine Induction to Initiate Extended-Release Buprenorphine for the Management of Opioid Use Disorder in an Outpatient setting: A Retrospective Case Series — Alaa Al Hawamdeh
- Life-Threatening Cardiotoxicity from Chronic High-Dose Loperamide Misuse: A Case Report — Gulcan Yildiz
- 7-Hydroxymitragynine Dependence with Severe Functional Impairment: Rapid Stabilization on Buprenorphine/Naloxone — Jason Della Vecchia
- Mapping the Opioid Crisis: County-Level Hotspots, Cold Spots, and the Geographic Divide in U.S. Overdose Mortality (2021-2023) — Snehitha Reddy Madini
- A Novel Intervention for Opioid Overdose Survivors: Engaging and Retaining in Treatment — Li Li
- A Qualitative Study on the Experiences, Barriers, and Understanding of Opioid Agonist Treatment Among Youth with Opioid Use Disorder in Vancouver, British Columbia — Hannah Schneiderman
- Acceptability and Feasibility of Optimo (Onsite Ptsd Treatment to Improve MOUD Outcomes): An Open Label Pilot of Adapted Cognitive Processing Therapy Delivered at Syringe Services Programs — Teresa Lopez-Castro
Schedule to be announced
Workshop · Workshops
Improving Emergency Department Protocols of Care for Overdose Survivors Using Suicide Prevention Frameworks
Joan Chen · Amira Athanasios · Jessica Sainz
Adapts suicide prevention frameworks to strengthen emergency department care pathways for overdose survivors.
Workshop · Workshops
The Vagus Nerve and Neurostimulation for Opioid Use Disorder and Chronic Pain
Zev Schuman-Olivier · Alta DeRoo
Explores vagus nerve stimulation and related neurostimulation approaches for opioid use disorder and chronic pain.
Other topics at this meeting
Substance Use Disorders 87Cannabis & Cannabinoids 17Alcohol Use Disorder 16Child & Adolescent 14Drug Interactions & Safety 13Education & Training 12Schizophrenia & Psychosis 12Emergency & Acute Psychiatry 11Digital Psychiatry & AI 8Practice, Policy & Workforce 8PTSD & Trauma 8Long-Acting Injectables 7